HSP90AB1 and glioblastoma: Thus, inhibiting Hsp90 activity will lead to downregulation of multiple oncogenic molecules and Hsp90 inhibitors may be effective chemotherapeutic agents for the treatment of GBM (Matts and Manjarrez, 2009).